GlassScriptPhysician profile
Justin Rose
NPI 1245586775
$7,952.02
in general payments reported to CMS, 2019-2025
10 companies · $2,860 in 2025
The $2,860 reported for 2025 was more than what 85% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.99 · 2020: $3,027 · 2021: $1,780 · 2022: $97.34 · 2023: $138 · 2024: $13.34 · 2025: $2,860.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,235 · Food and Beverage: $777.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,235.38 |
| Food and Beverage | $776.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,979.84 | 2019-2025 | Da Vinci Surgical System |
| Ethicon INC. | $2,453.26 | 2025 | Monarch Platform |
| Medical Device Business Services, INC. | $294.21 | 2025 | |
| Genentech USA, INC. | $97.34 | 2022 | |
| Medtronic, INC. | $38.51 | 2023 | Linq II |
| Ethicon US, LLC | $27.32 | 2025 | Vistaseal, Stratafix |
| Baxter Healthcare | $17.32 | 2025 | Perclot |
| Smith+Nephew, INC. | $16.02 | 2023 | Stravix, Grafix Pl, Oasis |
| Innovation Technologies INC | $14.86 | 2025 | Irrisept |
| Mimedx Group, INC. | $13.34 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Rose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.